NasdaqGS:CLOVHealthcare
Clover Health (CLOV) Stock Valuation After Court-Ordered Medicare Star Rating Upgrade
A U.S. District Court ordered the Centers for Medicare & Medicaid Services to raise Clover Health Investments (CLOV) 2026 Medicare Star Rating from 3.5 to 4.5 stars, which will reshape its CMS payments and bonus eligibility for 2027.
See our latest analysis for Clover Health Investments.
After the court ordered Star Rating upgrade, investor interest has been strong, with Clover’s 7 day share price return of 23.5% and 90 day share price return of 138.89%. The 3 year total shareholder return is...